New Delhi [India], August 13 (ANI): Serum Institute of India's chairman and managing director Cyrus Poonawalla on Friday praised the Narendra Modi government for bringing reforms in the vaccine industry for getting permissions and licences on priority and said difficulties to get licenses an
New Delhi [India], August 6 (ANI): In order to ramp up COVID-19 vaccine supply in the country, Union Health Minister Mansukh Mandaviya on Friday met Serum Institute of India (SII) CEO Adar Poonawalla in the national capital and held a discussion over the supply of Covishield vaccine.
New Delhi [India], August 6 (ANI): More than 136 crore COVID-19 vaccine doses are expected to be available till the end of this year, informed the Centre.
New Delhi [India], July 30 (ANI): The Confederation of Indian Industry (CII) has entered into an agreement with the Serum Institute of India (SII) to accelerate COVID-19 vaccination in partnership with industry, including healthcare providers.
Paris [France), July 19 (ANI): France on Monday included Covishield produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University in the list of approved vaccines for travel to the country.
New Delhi [India], July 17 (ANI): Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII) on Saturday said that it was good news for international travellers that Covishield, the Indian version of the Oxford-Astrazeneca vaccine was now recognised and accepted by 16 E
New Delhi [India], July 16 (ANI): The European Medicines Agency (EMA) said it has not received any application from the COVID-19 vaccine Covishield maker Serum Institute of India (SII) for authorisation.
New Delhi [India], July 13 (ANI): The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, and Serum Institute of India (SII), announced cooperation to produce in India the Russian Sputnik vaccine against coronavirus.
Moscow [Russia], July 13 (ANI): The first batch of Sputnik vaccine is expected to be produced at Serum Institute of India (SII)'s facilities in September, said Russian Direct Investment Fund (RDIF), the country's sovereign wealth fund on Tuesday.
Geneva [Switzerland], July 10 (ANI): World Health Organisation (WHO) chief scientist Soumya Swaminathan on Friday said 15 countries in the European Union (EU) now recognise Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University
New Delhi [India], July 9 (ANI): Belgium has recognised the Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University, said the Embassy of Belgium in India on Friday.
Pune (Maharashtra) [India], July 2 (ANI): Union Minister Mansukh Mandaviya on Friday visited a vaccine manufacturing plant of the Serum Institute of India in Pune to review the production of vaccines.